Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Portfolio > Alternative Investments > Hedge Funds

Allstate Division Funds Breast Cancer Study

Your article was successfully shared with the contacts you provided.

Allstate Corp.’s voluntary benefits unit is helping to pay for research for an experimental vaccine against breast cancer.

The Allstate Workplace Division, a subsidiary of Allstate, Northbrook, Ill., has given $220,426 through Gateway for Cancer Research, Schaumburg, Ill., for a clinical trial of a vaccine that may fight Stage IV breast cancer.

The vaccine potentially could enhance the survival chances of women with late-stage breast cancer and of people at high risk of being diagnosed with the disease, Allstate says.

The trial will evaluate a new mammaglobin-A DNA vaccine to be used in efforts to treat the disease.

Mammaglobin-A, a protein found almost exclusively in breast tissue, is present at much higher levels in breast cancer and is considered a reliable marker for the disease.

William Gillanders of Washington University is in charge of the research.


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.